Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Holders of 5% or more of TLIS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Talis Biomedical Corp, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Talis Biomedical Corp on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Talis Biomedical Corp, newest first.
No Schedule 13D or 13G filings on Talis Biomedical Corp are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Talis Biomedical Corp shares.
No Form 144 notices for Talis Biomedical Corp are on file.